3D 세포 배양 시장 : 2027년까지의 세계 예측

출판 : MarketsandMarkets(마켓츠앤드마켓츠)출판년월 : 2022년05월

3D 세포 배양 시장 : 유형(하이드로겔, ECM, 행잉드롭, 바이오리액터, 마이크로플루이딕스, 자기부상), 용도(암, 줄기세포, 독물학, 조직공학), 최종 사용자(제약, 생명공학, 연구, 화장품), 지역별 – 2027년까지의 세계 예측

3D Cell Culture Market by Type (Hydrogel, ECM, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharma, Biotech, Research, Cosmetics), Region – Global Forecast to 2027

페이지수 222
도표수 243
구성 영문조사보고서
가격

리포트목차    주문/문의    납기/라이센스안내

Sample Request

The global 3D cell culture market is valued at an estimated USD 1.3 billion in 2022 and is projected to reach USD 2.6 billion by 2027, at a CAGR of 15.6% during the forecast period. The growth of this market is mainly driven by factors such as the increasing focus on developing alternative methods to animal testing, growing focus on personalized medicine, increasing incidence of chronic diseases, and the availability of funding for research.
전 세계 3D 세포 배양 시장은 2022년에 13억 달러로 추산되며 예측 기간 동안 CAGR 15.6%로 2027년까지 26억 달러에 이를 것으로 예상됩니다. 이 시장의 성장은 주로 동물 실험에 대한 대체 방법 개발에 대한 관심 증가, 개인 맞춤 의학에 대한 관심 증가, 만성 질환 발병률 증가 및 연구 자금 조달 가능성과 같은 요인에 의해 주도됩니다.

On the other hand, a lack of infrastructure for 3D cell-based research and the high cost of cell biology research are expected to restrain the growth of this market during the forecast period.

“The scaffold-based 3D cell culture segment accounted for the highest growth rate in the 3D Cell culture market, by type, during the forecast period”
In 2021, the scaffold-based 3D cell culture segment accounted for the highest growth rate. The advantages of scaffolds in 3D cell culture, such as structural rigidity, the availability of attachment points, and support, have greatly driven the preference for scaffold-based 3D cell cultures and ensured the large share of this segment.

“Asia Pacific: The fastest-growing region in the 3D Cell culture market”
The Asia Pacific market is estimated to record the highest CAGR during the forecast period. This is attributed to the presence of favorable regulatory guidelines, government support for cell culture-based vaccine production, low manufacturing costs, and the growing focus of global market players on emerging Asian countries.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 80% and Demand Side 20%
• By Designation: C-level – 45%, D-level – 30%, and Others – 25%
• By Region: North America -20%, Europe -10%, Asia-Pacific -55%, Latin America -10%, Middle East & Africa- 5%
List of Companies Profiled in the Report:
• Thermo Fisher Scientific (US)
• Merck KGaA (Germany)
• Corning Incorporated (US)
• Lonza Group AG (Switzerland)
• Avantor Inc. (US)
• Tecan Trading AG (Switzerland)
• 3D Biotek LLC (US)
• Emulate Inc. (US)
• CN Bio Innovations (UK)
• InSphero AG (Switzerland)
• Greiner Bio-One International GmbH (Austria)
• REPROCELL Inc. (Japan)
• Kirkstall Ltd (UK)
• MIMETAS BV (Netherlands)
• PromoCell GmbH (Germany)
• TissUse GmbH (Germany)
• Synthecon Incorporated (US)
• QGel SA (Switzerland)
• Lena Biosciences (US)
• Cellendes GmbH (Germany)
• Advanced BioMatrix Inc. (Part of BICO Group) (US)
• Visikol Inc. (US)
• SynVivo Inc. (US)
• UAB Ferentis (Lithuania)
• Hamilton Company(US)


Research Coverage:
This report provides a detailed picture of the global 3D Cell culture Market. It aims at estimating the size and future growth potential of the market across different segments such as the type, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall 3D Cell culture Market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, challenges, trends, and opportunities.


목차

TABLE OF CONTENTS

1 INTRODUCTION (Page No. – 30)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. – 34)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: 3D CELL CULTURE MARKET
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 3D CELL CULTURE MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2021
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2021
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 6 3D CELL CULTURE MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
FIGURE 7 3D CELL CULTURE MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
2.4 DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.5.1 COVID-19-SPECIFIC ASSUMPTIONS
2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. – 45)
FIGURE 9 3D CELL CULTURE MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 10 3D CELL CULTURE MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 11 3D CELL CULTURE MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE 3D CELL CULTURE MARKET

4 PREMIUM INSIGHTS (Page No. – 48)
4.1 3D CELL CULTURE MARKET OVERVIEW
FIGURE 13 INCREASING FOCUS ON DEVELOPING ALTERNATIVES TO ANIMAL TESTING IS A MAJOR FACTOR DRIVING THE ADOPTION OF 3D CELL CULTURE SOLUTIONS
4.2 NORTH AMERICA: 3D CELL CULTURE MARKET, BY TYPE AND COUNTRY (2021)
FIGURE 14 SCAFFOLD-BASED 3D CELL CULTURES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN 3D CELL CULTURE MARKET IN 2021
4.3 3D CELL CULTURE MARKET SHARE, BY APPLICATION, 2022 VS. 2027
FIGURE 15 CANCER & STEM CELL RESEARCH WILL CONTINUE TO DOMINATE THE MARKET IN 2027
4.4 3D CELL CULTURE MARKET SHARE, BY END USER, 2021 (USD MILLION)
FIGURE 16 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES DOMINATED THE MARKET IN 2021
4.5 3D CELL CULTURE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 ASIA PACIFIC COUNTRIES TO REGISTER THE HIGHEST GROWTH RATE FROM 2022 TO 2027

5 MARKET OVERVIEW (Page No. – 52)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 3D CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing focus on developing alternatives to animal testing
5.2.1.2 Growing focus on personalized medicine
TABLE 1 GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES
5.2.1.3 Increasing incidence of chronic diseases
TABLE 2 PREVALENCE OF DIABETES, BY REGION, 2000 VS. 2030
TABLE 3 INCIDENCE OF CANCER, BY TYPE, 2020 VS. 2040
5.2.1.4 Availability of funding for research
5.2.1.5 Growing demand for 3D cell culture
5.2.2 RESTRAINTS
5.2.2.1 Lack of infrastructure for 3D cell-based research
5.2.2.2 High cost of cell biology research
5.2.3 OPPORTUNITIES
5.2.3.1 Emergence of microfluidics-based 3D cell culture
5.2.3.2 Emerging economies
5.2.3.3 Regenerative medicine as an alternative to organ transplantation
5.2.3.4 Risk of pandemics and communicable diseases
5.2.4 CHALLENGES
5.2.4.1 Lack of consistency in 3D cell culture products
5.2.4.2 Plastic waste disposal
TABLE 4 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS
5.3 RANGES/SCENARIOS
FIGURE 19 SPECTRUM OF SCENARIOS BASED ON THE IMPACT OF UNCERTAINTIES ON THE GROWTH OF THE 3D CELL CULTURE MARKET
5.4 IMPACT OF THE COVID-19 OUTBREAK ON THE 3D CELL CULTURE MARKET
FIGURE 20 3D CELL CULTURE MARKET SCENARIO WITH AND WITHOUT COVID-19 IMPACT, 2020–2022
FIGURE 21 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.5 PRICING ANALYSIS
TABLE 5 SELLING PRICE OF 3D CELL CULTURE PRODUCTS BY TOP PLAYERS
5.6 TECHNOLOGY ANALYSIS
TABLE 6 ADVANTAGES AND DISADVANTAGES OF 3D CELL CULTURE TECHNIQUES
TABLE 7 ADVANTAGES AND DISADVANTAGES OF 3D CELL CULTURE METHODS
5.7 PATENT ANALYSIS
FIGURE 22 PATENT APPLICATIONS FOR THE CELL CULTURE MARKET, JANUARY 2011–DECEMBER 2021
TABLE 8 INDICATIVE LIST OF PATENTS IN THE 3D CELL CULTURE MARKET
5.8 VALUE CHAIN ANALYSIS
FIGURE 23 VALUE CHAIN ANALYSIS OF THE 3D CELL CULTURE MARKET: RAW MATERIAL AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE
5.9 SUPPLY CHAIN ANALYSIS
FIGURE 24 3D CELL CULTURE MARKET: SUPPLY CHAIN ANALYSIS
5.10 ECOSYSTEM ANALYSIS OF THE 3D CELL CULTURE MARKET
TABLE 9 SUPPLY CHAIN ECOSYSTEM
5.11 KEY CONFERENCES & EVENTS IN 2022–2023
TABLE 10 3D CELL CULTURE MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.12 REGULATORY ANALYSIS
5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.13 PORTER’S FIVE FORCES ANALYSIS
TABLE 15 3D CELL CULTURE MARKET: PORTER’S FIVE FORCES ANALYSIS
5.13.1 THREAT OF NEW ENTRANTS
5.13.2 THREAT OF SUBSTITUTES
5.13.3 BARGAINING POWER OF SUPPLIERS
5.13.4 BARGAINING POWER OF BUYERS
5.13.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN THE BUYING PROCESS
FIGURE 25 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS OF 3D CELL CULTURE PRODUCTS
5.14.2 BUYING CRITERIA FOR 3D CELL CULTURE PRODUCTS
FIGURE 26 KEY BUYING CRITERIA FOR END USERS

6 3D CELL CULTURE MARKET, BY TYPE (Page No. – 79)
6.1 INTRODUCTION
TABLE 16 3D CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2 SCAFFOLD-BASED 3D CELL CULTURES
TABLE 17 SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 18 SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 19 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 20 EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 21 ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1 HYDROGELS/ECM ANALOGS
6.2.1.1 Hydrogels/ECM analogs dominate the scaffold-based 3D cell cultures market
TABLE 22 HYDROGELS/ECM ANALOGS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 23 NORTH AMERICA: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 24 EUROPE: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 25 ASIA PACIFIC: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2 SOLID SCAFFOLDS
6.2.2.1 Solid scaffolds are widely adopted in regenerative medicine and preclinical in vitro testing
TABLE 26 SOLID SCAFFOLDS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 27 NORTH AMERICA: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 28 EUROPE: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 29 ASIA PACIFIC: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3 MICROPATTERNED SURFACES
6.2.3.1 Micropatterned surfaces enhance the expression of enzymes levels and drug reactivity
TABLE 30 MICROPATTERNED SURFACES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 31 NORTH AMERICA: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 32 EUROPE: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 33 ASIA PACIFIC: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 SCAFFOLD-FREE 3D CELL CULTURES
TABLE 34 SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 35 SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 36 NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 37 EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 38 ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.1 LOW ATTACHMENT PLATES
6.3.1.1 Low attachment plates are expected to grow at the highest rate in the scaffold-free 3D cell cultures market
TABLE 39 LOW ATTACHMENT PLATES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 40 NORTH AMERICA: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 41 EUROPE: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 42 ASIA PACIFIC: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.2 HANGING DROP PLATES
6.3.2.1 Hanging drop plates are widely used in stem cell differentiation and cytotoxicity research
TABLE 43 HANGING DROP PLATES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 44 NORTH AMERICA: HANGING DROP PLATES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 45 EUROPE: HANGING DROP PLATES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 46 ASIA PACIFIC: HANGING DROP PLATES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.3 3D BIOREACTORS
6.3.3.1 3D bioreactors are commonly used in the mass production of cells
TABLE 47 3D BIOREACTORS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 48 NORTH AMERICA: 3D BIOREACTORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 49 EUROPE: 3D BIOREACTORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 50 ASIA PACIFIC: 3D BIOREACTORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.4 3D PETRI DISHES
6.3.4.1 Europe will witness the highest growth in the 3D Petri dishes market
TABLE 51 3D PETRI DISHES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 52 NORTH AMERICA: 3D PETRI DISHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 53 EUROPE: 3D PETRI DISHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 54 ASIA PACIFIC: 3D PETRI DISHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 MICROFLUIDICS-BASED 3D CELL CULTURES
6.4.1 MICROFLUIDICS-BASED 3D CELL CULTURES WILL GROW AT THE HIGHEST RATE IN THE 3D CELL CULTURE MARKET
TABLE 55 MICROFLUIDICS-BASED 3D CELL CULTURE MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 56 NORTH AMERICA: MICROFLUIDICS-BASED 3D CELL CULTURE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 57 EUROPE: MICROFLUIDICS-BASED 3D CELL CULTURE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 58 ASIA PACIFIC: MICROFLUIDICS-BASED 3D CELL CULTURE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.5 MAGNETIC & BIOPRINTED 3D CELL CULTURES
6.5.1 3D CELL CULTURE CAN BE FORMED WITHOUT MEDIA IN MAGNETIC LEVITATION
TABLE 59 MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 60 NORTH AMERICA: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 61 EUROPE: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 62 ASIA PACIFIC: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

7 3D CELL CULTURE MARKET, BY APPLICATION (Page No. – 100)
7.1 INTRODUCTION
TABLE 63 3D CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
7.2 CANCER & STEM CELL RESEARCH
7.2.1 RISING PREVALENCE OF CANCER IS A KEY FACTOR DRIVING THE GROWTH OF THIS SEGMENT
TABLE 64 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY REGION, 2020–2027 (USD MILLION)
TABLE 65 NORTH AMERICA: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 66 EUROPE: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 67 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 DRUG DISCOVERY & TOXICOLOGY TESTING
7.3.1 INCREASING ADOPTION OF PERSONALIZED MEDICINES TO SUPPORT MARKET GROWTH
TABLE 68 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY REGION, 2020–2027 (USD MILLION)
TABLE 69 NORTH AMERICA: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 70 EUROPE: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 71 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE
7.4.1 INCREASING TISSUE ENGINEERING & REGENERATIVE MEDICINE RESEARCH TO DRIVE THIS MARKET
TABLE 72 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2020–2027 (USD MILLION)
TABLE 73 NORTH AMERICA: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 74 EUROPE: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 75 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2020–2027 (USD MILLION)

8 3D CELL CULTURE MARKET, BY END USER (Page No. – 108)
    8.1 INTRODUCTION
TABLE 76 3D CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST END USERS OF 3D CELL CULTURE PRODUCTS
TABLE 77 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION)
TABLE 78 NORTH AMERICA: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 79 EUROPE: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 80 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 RESEARCH INSTITUTES
8.3.1 INCREASING GOVERNMENT FUNDING FOR RESEARCH & HIGH PREVALENCE OF CANCER ARE DRIVING MARKET GROWTH
TABLE 81 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION)
TABLE 82 NORTH AMERICA: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 83 EUROPE: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 84 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 COSMETICS INDUSTRY
8.4.1 FOCUS ON DEVELOPING ALTERNATIVES TO ANIMAL TESTING IS A KEY FACTOR DRIVING MARKET GROWTH
TABLE 85 3D CELL CULTURE MARKET FOR THE COSMETICS INDUSTRY, BY REGION, 2020–2027 (USD MILLION)
TABLE 86 NORTH AMERICA: 3D CELL CULTURE MARKET FOR THE COSMETICS INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 87 EUROPE: 3D CELL CULTURE MARKET FOR THE COSMETICS INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 88 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR THE COSMETICS INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)
8.5 OTHER END USERS
TABLE 89 3D CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)
TABLE 90 NORTH AMERICA: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 91 EUROPE: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 92 ASIA PACIFIC: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)

9 3D CELL CULTURE MARKET, BY REGION (Page No. – 117)
9.1 INTRODUCTION
TABLE 93 3D CELL CULTURE MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: 3D CELL CULTURE MARKET SNAPSHOT
TABLE 94 NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 95 NORTH AMERICA: 3D CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 96 NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 98 NORTH AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 99 NORTH AMERICA: 3D CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominates the North American market
TABLE 100 US: 3D CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 101 US: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 102 US: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 US: 3D CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 104 US: 3D CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Advancements in regenerative medicine to drive market growth in Canada
TABLE 105 CANADA: 3D CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 106 CANADA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 107 CANADA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 108 CANADA: 3D CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 109 CANADA: 3D CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3 EUROPE
TABLE 110 EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 111 EUROPE: 3D CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 112 EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 113 EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 114 EUROPE: 3D CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 115 EUROPE: 3D CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany dominates the 3D cell culture market in Europe
TABLE 116 GERMANY: 3D CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 117 GERMANY: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 GERMANY: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 119 GERMANY: 3D CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 120 GERMANY: 3D CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.2 UK
9.3.2.1 Growth in the life sciences industry to drive market growth in the UK
TABLE 121 UK: 3D CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 122 UK: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 123 UK: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 124 UK: 3D CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 125 UK: 3D CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Biotech industry growth supports the market in France
TABLE 126 FRANCE: 3D CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 127 FRANCE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 128 FRANCE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 129 FRANCE: 3D CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 130 FRANCE: 3D CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Italy is a leading life science research hub in Europe
TABLE 131 ITALY: 3D CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 132 ITALY: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 ITALY: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 134 ITALY: 3D CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 135 ITALY: 3D CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Increasing funding from private and public organizations to aid market growth in Spain
TABLE 136 SPAIN: 3D CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 137 SPAIN: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 138 SPAIN: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 139 SPAIN: 3D CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 140 SPAIN: 3D CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.6 ROE
TABLE 141 ROE: 3D CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 142 ROE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 143 ROE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 ROE: 3D CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 145 ROE: 3D CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: 3D CELL CULTURE MARKET SNAPSHOT
TABLE 146 APAC: 3D CELL CULTURE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 147 APAC: 3D CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 148 APAC: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 149 APAC: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 150 APAC: 3D CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 151 APAC: 3D CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.1 CHINA
9.4.1.1 Government support & strategic initiatives by key players to strengthen the biotechnology sector in China
TABLE 152 CHINA: 3D CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 153 CHINA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 154 CHINA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 155 CHINA: 3D CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 156 CHINA: 3D CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Rising cancer rate, growing geriatric population, and subsequent rise in healthcare spending to drive the market growth
TABLE 157 JAPAN: 3D CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 158 JAPAN: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 159 JAPAN: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 160 JAPAN: 3D CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 161 JAPAN: 3D CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Growth in the life sciences industry to support market growth in India
TABLE 162 INDIA: 3D CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 163 INDIA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 164 INDIA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 165 INDIA: 3D CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 166 INDIA: 3D CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.4 ROAPAC
TABLE 167 ROAPAC: 3D CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 168 ROAPAC: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 169 ROAPAC: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 170 ROAPAC: 3D CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 171 ROAPAC: 3D CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION).
9.5 LATIN AMERICA
9.5.1 RISING CANCER RATE AND GROWING SUPPORT FOR RESEARCH TO DRIVE MARKET GROWTH
TABLE 172 LATIN AMERICA: 3D CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 173 LATIN AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 174 LATIN AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 175 LATIN AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 176 LATIN AMERICA: 3D CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 INCREASING FUNDING AND PARTNERSHIPS IN RESEARCH TO SUPPORT MARKET GROWTH
TABLE 177 MIDDLE EAST & AFRICA: 3D CELL CULTURE MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 178 MIDDLE EAST & AFRICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 MIDDLE EAST & AFRICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 180 MIDDLE EAST & AFRICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 181 MIDDLE EAST & AFRICA: 3D CELL CULTURE MARKET, BY END USER, 2020–2027 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. – 162)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 29 KEY DEVELOPMENTS IN THE 3D CELL CULTURE MARKET, 2019–2022
10.3 MARKET SHARE ANALYSIS
FIGURE 30 3D CELL CULTURE MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021
TABLE 182 3D CELL CULTURE MARKET: DEGREE OF COMPETITION
10.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 31 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN THE 3D CELL CULTURE MARKET, 2019–2021
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 32 3D CELL CULTURE MARKET: COMPANY EVALUATION QUADRANT, 2021
10.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 33 3D CELL CULTURE MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021
10.7 COMPANY FOOTPRINT ANALYSIS
10.7.1 COMPANY PRODUCT FOOTPRINT
TABLE 183 COMPANY PRODUCT FOOTPRINT: 3D CELL CULTURE MARKET (2021)
10.7.2 COMPANY REGIONAL FOOTPRINT
TABLE 184 COMPANY REGIONAL FOOTPRINT: 3D CELL CULTURE MARKET (2021)
10.7.3 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
TABLE 185 3D CELL CULTURE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 186 3D CELL CULTURE MARKET: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
10.8 COMPETITIVE SCENARIO
TABLE 187 PRODUCT LAUNCHES
TABLE 188 DEALS
TABLE 189 OTHER DEVELOPMENTS

11 COMPANY PROFILES (Page No. – 178)
11.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 THERMO FISHER SCIENTIFIC, INC.
TABLE 190 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 34 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2020)
11.1.2 MERCK KGAA
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2021)
11.1.3 CORNING INCORPORATED
TABLE 192 CORNING INCORPORATED: BUSINESS OVERVIEW
FIGURE 36 CORNING INCORPORATED: COMPANY SNAPSHOT (2021)
11.1.4 LONZA GROUP AG
TABLE 193 LONZA GROUP AG: BUSINESS OVERVIEW
FIGURE 37 LONZA GROUP AG: COMPANY SNAPSHOT (2020)
11.1.5 TECAN TRADING AG
TABLE 194 TECAN TRADING AG: BUSINESS OVERVIEW
FIGURE 38 TECAN TRADING AG: COMPANY SNAPSHOT (2021)
11.1.6 AVANTOR, INC.
TABLE 195 AVANTOR, INC.: BUSINESS OVERVIEW
FIGURE 39 AVANTOR, INC: COMPANY SNAPSHOT (2021)
11.1.7 REPROCELL INC.
TABLE 196 REPROCELL: BUSINESS OVERVIEW
11.1.8 3D BIOTEK LLC
TABLE 197 3D BIOTEK LLC: BUSINESS OVERVIEW
11.1.9 EMULATE, INC.
TABLE 198 EMULATE, INC.: BUSINESS OVERVIEW
11.1.10 CN BIO INNOVATIONS LIMITED
TABLE 199 CN BIO INNOVATIONS LIMITED: BUSINESS OVERVIEW
11.1.11 SYNTHECON, INCORPORATED
TABLE 200 SYNTHECON, INCORPORATED: BUSINESS OVERVIEW
11.1.12 INSPHERO AG
TABLE 201 INSPHERO AG: BUSINESS OVERVIEW
11.1.13 KIRKSTALL LTD.
TABLE 202 KIRKSTALL LTD.: BUSINESS OVERVIEW
11.1.14 MIMETAS BV
TABLE 203 MIMETAS BV: BUSINESS OVERVIEW
11.1.15 TISSUSE GMBH
TABLE 204 TISSUSE GMBH: BUSINESS OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS
11.2.1 HAMILTON COMPANY
11.2.2 QGEL SA
11.2.3 LENA BIOSCIENCES
11.2.4 CELLENDES GMBH
11.2.5 UAB FERENTIS
11.2.6 GREINER BIO-ONE INTERNATIONAL GMBH
11.2.7 PROMOCELL GMBH
11.2.8 ADVANCED BIOMATRIX, INC. (PART OF BICO GROUP)
11.2.9 VISIKOL, INC. (FORMERLY HUREL CORPORATION)
11.2.10 SYNVIVO INC.

12 APPENDIX (Page No. – 224)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS


    • 리포트 제목은 자동으로 입력됩니다.
    • *항목은 필수항목입니다.

    의뢰분류*

    성함*

    회사명*

    부서명

    이메일*

    전화번호

    저희 사이트를 알게 된 경로를 가르쳐 주세요.

    문의 내용*

     

    ※개인정보보호정책은여기에서 확인 가능합니다。

    Email 문의도 받고 있습니다.
    아래 주소이며 죄송하지만 "(at)"을 "@"로 바꾸어 보내주시길 부탁드립니다.
    mooneui(at)chosareport-korea.com